(NASDAQ:BIOA), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to […]

(NasdaqGM:SYM), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Symbotic Inc. (NASDAQ: SYM). Shareholders who purchased shares of SYM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake

(NASDAQ:AEHR), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Aehr Test Systems, Inc. (NASDAQ: AEHR). Shareholders who purchased shares of AEHR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required

(NASDAQ:XRAY), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who purchased shares of XRAY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NasdaqGM:APLT), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NASDAQ:ASPI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of ASP Isotopes Inc. (NASDAQ: ASPI). Shareholders who purchased shares of ASPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NYSE:ZETA), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Zeta Global Holdings Corp. (NYSE: ZETA). Shareholders who purchased shares of ZETA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required

(NASDAQ:REGN), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to

(NYSE:ZETA), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Zeta Global Holdings Corp. (NYSE: ZETA). Shareholders who purchased shares of ZETA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required

(NASDAQ:CELH), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Celsius Holdings, Inc. (NASDAQ: CELH). Shareholders who purchased shares of CELH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to